D'Haens GR - Search Results

1

Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab clearance.

Colman RJ, Mizuno T, Fukushima K, Haslam DB, Hyams JS, Boyle B, Noe JD, D'Haens GR, Van Limbergen J, Chun K, Yang J, Denson LA, Ollberding NJ, Vinks AA, Minar P. Colman RJ, et al. Aliment Pharmacol Ther. 2023 Mar;57(5):524-539. doi: 10.1111/apt.17277. Epub 2022 Oct 31. Aliment Pharmacol Ther. 2023. PMID: 36314265 Free PMC article.

2

Review article: pharmacological aspects of anti-TNF biosimilars in inflammatory bowel diseases.

Papamichael K, Van Stappen T, Jairath V, Gecse K, Khanna R, D'Haens G, Vermeire S, Gils A, Feagan BG, Levesque BG, Vande Casteele N. Papamichael K, et al. Aliment Pharmacol Ther. 2015 Nov;42(10):1158-69. doi: 10.1111/apt.13402. Epub 2015 Sep 13. Aliment Pharmacol Ther. 2015. PMID: 26365281 Free article. Review.

3

Suppression of anti-drug antibodies to infliximab or adalimumab with the addition of an immunomodulator in patients with inflammatory bowel disease.

Strik AS, van den Brink GR, Ponsioen C, Mathot R, Löwenberg M, D'Haens GR. Strik AS, et al. Aliment Pharmacol Ther. 2017 Apr;45(8):1128-1134. doi: 10.1111/apt.13994. Epub 2017 Feb 23. Aliment Pharmacol Ther. 2017. PMID: 28230306

4

Physicians' perspective on the clinical meaningfulness of inflammatory bowel disease trial results: an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) survey.

Olivera P, Sandborn WJ, Panés J, Baumann C, D'Haens G, Vermeire S, Danese S, Peyrin-Biroulet L. Olivera P, et al. Aliment Pharmacol Ther. 2018 Mar;47(6):773-783. doi: 10.1111/apt.14514. Epub 2018 Jan 19. Aliment Pharmacol Ther. 2018. PMID: 29349829

5

Letter: the addition of an immunosuppressant in patients with unsatisfactory response to vedolizumab-Authors' reply.

Strik AS, D'Haens GR. Strik AS, et al. Aliment Pharmacol Ther. 2018 Apr;47(7):1041-1042. doi: 10.1111/apt.14570. Aliment Pharmacol Ther. 2018. PMID: 29512914 No abstract available.

6

Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis.

Ma C, Guizzetti L, Panaccione R, Fedorak RN, Pai RK, Parker CE, Nguyen TM, Khanna R, Vande Casteele N, D'Haens G, Sandborn WJ, Feagan BG, Jairath V. Ma C, et al. Aliment Pharmacol Ther. 2018 Jun;47(12):1578-1596. doi: 10.1111/apt.14672. Epub 2018 Apr 25. Aliment Pharmacol Ther. 2018. PMID: 29696670

7

Subcutaneous rather than intravenous ustekinumab induction is associated with comparable circulating drug levels and early clinical response: a pilot study.

Rowan CR, Keegan D, Byrne K, Cullen G, Mulcahy HE, Sheridan J, Ryan EJ, de Vries A, D'Haens G, Doherty GA. Rowan CR, et al. Aliment Pharmacol Ther. 2018 Aug;48(3):333-339. doi: 10.1111/apt.14834. Epub 2018 Jun 19. Aliment Pharmacol Ther. 2018. PMID: 29920697 Clinical Trial.

8

Systematic review: predictive biomarkers of therapeutic response in inflammatory bowel disease-personalised medicine in its infancy.

Stevens TW, Matheeuwsen M, Lönnkvist MH, Parker CE, Wildenberg ME, Gecse KB, D'Haens GR. Stevens TW, et al. Aliment Pharmacol Ther. 2018 Dec;48(11-12):1213-1231. doi: 10.1111/apt.15033. Epub 2018 Oct 30. Aliment Pharmacol Ther. 2018. PMID: 30378142

9

Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn's disease.

Novak G, Stevens T, Van Viegen T, Bossuyt P, Štabuc B, Jeyarajah J, Zou G, Gaemers IC, McKee TD, Fu F, Shackelton LM, Khanna R, van den Brink GR, Sandborn WJ, Feagan BG, Pai RK, Jairath V, Vande Casteele N, D'Haens G. Novak G, et al. Aliment Pharmacol Ther. 2019 Jun;49(11):1401-1409. doi: 10.1111/apt.15250. Epub 2019 Apr 15. Aliment Pharmacol Ther. 2019. PMID: 30983024

10

Systematic review with meta-analysis: risk factors for thiopurine-induced leukopenia in IBD.

van Gennep S, Konté K, Meijer B, Heymans MW, D'Haens GR, Löwenberg M, de Boer NKH. van Gennep S, et al. Aliment Pharmacol Ther. 2019 Sep;50(5):484-506. doi: 10.1111/apt.15403. Epub 2019 Jul 25. Aliment Pharmacol Ther. 2019. PMID: 31342537

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

434 results

Search Page